Rankings
▼
Calendar
PLSE FY 2021 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
PLSE
Pulse Biosciences, Inc.
$1B
FY 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1M
Gross Profit
-$550,000
-38.8% margin
Operating Income
-$63M
-4443.9% margin
Net Income
-$64M
-4489.4% margin
EPS (Diluted)
$-2.28
Cash Flow
Operating Cash Flow
-$54M
Free Cash Flow
-$55M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$54M
Total Liabilities
$19M
Stockholders' Equity
$36M
Cash & Equivalents
$29M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
-$550,000
-$1M
+49.8%
Operating Income
-$63M
-$50M
-26.1%
Net Income
-$64M
-$50M
-28.0%
← Q4 2020
All Quarters
Q1 2021 →